TRACK-CF prospective cohort study: understanding early cystic fibrosis lung disease

BackgroundLung disease as major cause for morbidity in patients with cystic fibrosis (CF) starts early in life. Its large phenotypic heterogeneity is partially explained by the genotype but other contributing factors are not well delineated. The close relationship between mucus, inflammation and inf...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Steinke, Eva (VerfasserIn) , Sommerburg, Olaf (VerfasserIn) , Gräber, Simon Y. (VerfasserIn) , Joachim, Cornelia (VerfasserIn) , Labitzke, Christiane (VerfasserIn) , Nissen, Gyde Anna Simone (VerfasserIn) , Ricklefs, Isabell (VerfasserIn) , Rudolf, Isabel (VerfasserIn) , Kopp, Matthias (VerfasserIn) , Dittrich, Anna-Maria (VerfasserIn) , Mall, Marcus A. (VerfasserIn) , Stahl, Mirjam (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2022
In: Frontiers in medicine
Year: 2022, Jahrgang: 9, Pages: 1-11
ISSN:2296-858X
DOI:10.3389/fmed.2022.1034290
Online-Zugang:Resolving-System, kostenfrei, Volltext: https://doi.org/10.3389/fmed.2022.1034290
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/articles/10.3389/fmed.2022.1034290
Volltext
Verfasserangaben:Eva Steinke, Olaf Sommerburg, Simon Y. Graeber, Cornelia Joachim, Christiane Labitzke, Gyde Nissen, Isabell Ricklefs, Isa Rudolf, Matthias V. Kopp, Anna-Maria Dittrich, Marcus A. Mall, Mirjam Stahl

MARC

LEADER 00000caa a2200000 c 4500
001 1848967179
003 DE-627
005 20230706222838.0
007 cr uuu---uuuuu
008 230614s2022 xx |||||o 00| ||eng c
024 7 |a 10.3389/fmed.2022.1034290  |2 doi 
035 |a (DE-627)1848967179 
035 |a (DE-599)KXP1848967179 
035 |a (OCoLC)1389533643 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Steinke, Eva  |e VerfasserIn  |0 (DE-588)1265220352  |0 (DE-627)181426938X  |4 aut 
245 1 0 |a TRACK-CF prospective cohort study  |b understanding early cystic fibrosis lung disease  |c Eva Steinke, Olaf Sommerburg, Simon Y. Graeber, Cornelia Joachim, Christiane Labitzke, Gyde Nissen, Isabell Ricklefs, Isa Rudolf, Matthias V. Kopp, Anna-Maria Dittrich, Marcus A. Mall, Mirjam Stahl 
264 1 |c 2022 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.06.2023 
500 |a Online veröffentlicht: 6. Januar 2023 
520 |a BackgroundLung disease as major cause for morbidity in patients with cystic fibrosis (CF) starts early in life. Its large phenotypic heterogeneity is partially explained by the genotype but other contributing factors are not well delineated. The close relationship between mucus, inflammation and infection, drives morpho-functional alterations already early in pediatric CF disease, The TRACK-CF cohort has been established to gain insight to disease onset and progression, assessed by lung function testing and imaging to capture morpho-functional changes and to associate these with risk and protective factors, which contribute to the variation of the CF lung disease progression.Methods and designTRACK-CF is a prospective, longitudinal, observational cohort study following patients with CF from newborn screening or clinical diagnosis throughout childhood. The study protocol includes monthly telephone interviews, quarterly visits with microbiological sampling and multiple-breath washout and as well as a yearly chest magnetic resonance imaging. A parallel biobank has been set up to enable the translation from the deeply phenotyped cohort to the validation of relevant biomarkers. The main goal is to determine influencing factors by the combined analysis of clinical information and biomaterials. Primary endpoints are the lung clearance index by multiple breath washout and semi-quantitative magnetic resonance imaging scores. The frequency of pulmonary exacerbations, infection with pro-inflammatory pathogens and anthropometric data are defined as secondary endpoints.DiscussionThis extensive cohort includes children after diagnosis with comprehensive monitoring throughout childhood. The unique composition and the use of validated, sensitive methods with the attached biobank bears the potential to decisively advance the understanding of early CF lung disease.Ethics and trial registrationThe study protocol was approved by the Ethics Committees of the University of Heidelberg (approval S-211/2011) and each participating site and is registered at clinicaltrials.gov (NCT02270476). 
700 1 |a Sommerburg, Olaf  |d 1967-  |e VerfasserIn  |0 (DE-588)172907470  |0 (DE-627)69783543X  |0 (DE-576)133762270  |4 aut 
700 1 |a Gräber, Simon Y.  |d 1985-  |e VerfasserIn  |0 (DE-588)1056936177  |0 (DE-627)794247199  |0 (DE-576)412922029  |4 aut 
700 1 |a Joachim, Cornelia  |e VerfasserIn  |0 (DE-588)1070637459  |0 (DE-627)824417267  |0 (DE-576)432175776  |4 aut 
700 1 |a Labitzke, Christiane  |e VerfasserIn  |4 aut 
700 1 |a Nissen, Gyde Anna Simone  |d 1991-  |e VerfasserIn  |0 (DE-588)1189943670  |0 (DE-627)1668689723  |4 aut 
700 1 |a Ricklefs, Isabell  |e VerfasserIn  |4 aut 
700 1 |a Rudolf, Isabel  |d 1972-  |e VerfasserIn  |0 (DE-588)128713801  |0 (DE-627)378310291  |0 (DE-576)297294474  |4 aut 
700 1 |a Kopp, Matthias  |d 1965-  |e VerfasserIn  |0 (DE-588)130005657  |0 (DE-627)486919404  |0 (DE-576)297946307  |4 aut 
700 1 |a Dittrich, Anna-Maria  |d 1973-  |e VerfasserIn  |0 (DE-588)122927362  |0 (DE-627)706094573  |0 (DE-576)293479569  |4 aut 
700 1 |a Mall, Marcus A.  |d 1975-  |e VerfasserIn  |0 (DE-588)115507795  |0 (DE-627)691370532  |0 (DE-576)28992152X  |4 aut 
700 1 |a Stahl, Mirjam  |e VerfasserIn  |0 (DE-588)1050007778  |0 (DE-627)783125836  |0 (DE-576)404265367  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in medicine  |d Lausanne : Frontiers Media, 2014  |g 9(2022), Artikel-ID 1034290, Seite 1-11  |h Online-Ressource  |w (DE-627)789482991  |w (DE-600)2775999-4  |w (DE-576)408729597  |x 2296-858X  |7 nnas  |a TRACK-CF prospective cohort study understanding early cystic fibrosis lung disease 
773 1 8 |g volume:9  |g year:2022  |g elocationid:1034290  |g pages:1-11  |g extent:11  |a TRACK-CF prospective cohort study understanding early cystic fibrosis lung disease 
856 4 0 |u https://doi.org/10.3389/fmed.2022.1034290  |x Resolving-System  |x Verlag  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fmed.2022.1034290  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20230614 
993 |a Article 
994 |a 2022 
998 |g 1050007778  |a Stahl, Mirjam  |m 1050007778:Stahl, Mirjam  |d 50000  |e 50000PS1050007778  |k 0/50000/  |p 12  |y j 
998 |g 1070637459  |a Joachim, Cornelia  |m 1070637459:Joachim, Cornelia  |d 910000  |d 910500  |e 910000PJ1070637459  |e 910500PJ1070637459  |k 0/910000/  |k 1/910000/910500/  |p 4 
998 |g 172907470  |a Sommerburg, Olaf  |m 172907470:Sommerburg, Olaf  |d 910000  |d 910500  |d 50000  |e 910000PS172907470  |e 910500PS172907470  |e 50000PS172907470  |k 0/910000/  |k 1/910000/910500/  |k 0/50000/  |p 2 
999 |a KXP-PPN1848967179  |e 4336958815 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 14.06.2023","Online veröffentlicht: 6. Januar 2023"],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"2022"}],"title":[{"subtitle":"understanding early cystic fibrosis lung disease","title_sort":"TRACK-CF prospective cohort study","title":"TRACK-CF prospective cohort study"}],"id":{"eki":["1848967179"],"doi":["10.3389/fmed.2022.1034290"]},"recId":"1848967179","relHost":[{"part":{"text":"9(2022), Artikel-ID 1034290, Seite 1-11","extent":"11","volume":"9","pages":"1-11","year":"2022"},"titleAlt":[{"title":"FMED"},{"title":"Front. Med."}],"language":["eng"],"id":{"issn":["2296-858X"],"zdb":["2775999-4"],"eki":["789482991"]},"recId":"789482991","physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"TRACK-CF prospective cohort study understanding early cystic fibrosis lung diseaseFrontiers in medicine","title":[{"title":"Frontiers in medicine","title_sort":"Frontiers in medicine"}],"origin":[{"publisherPlace":"Lausanne","dateIssuedDisp":"2014-","dateIssuedKey":"2014","publisher":"Frontiers Media"}],"note":["Gesehen am 09.02.2021"],"pubHistory":["2014 -"]}],"name":{"displayForm":["Eva Steinke, Olaf Sommerburg, Simon Y. Graeber, Cornelia Joachim, Christiane Labitzke, Gyde Nissen, Isabell Ricklefs, Isa Rudolf, Matthias V. Kopp, Anna-Maria Dittrich, Marcus A. Mall, Mirjam Stahl"]},"physDesc":[{"extent":"11 S."}],"person":[{"display":"Steinke, Eva","family":"Steinke","role":"aut","given":"Eva"},{"family":"Sommerburg","display":"Sommerburg, Olaf","role":"aut","given":"Olaf"},{"given":"Simon Y.","role":"aut","display":"Gräber, Simon Y.","family":"Gräber"},{"role":"aut","given":"Cornelia","family":"Joachim","display":"Joachim, Cornelia"},{"display":"Labitzke, Christiane","family":"Labitzke","role":"aut","given":"Christiane"},{"given":"Gyde Anna Simone","role":"aut","display":"Nissen, Gyde Anna Simone","family":"Nissen"},{"family":"Ricklefs","display":"Ricklefs, Isabell","given":"Isabell","role":"aut"},{"role":"aut","given":"Isabel","family":"Rudolf","display":"Rudolf, Isabel"},{"family":"Kopp","display":"Kopp, Matthias","role":"aut","given":"Matthias"},{"role":"aut","given":"Anna-Maria","family":"Dittrich","display":"Dittrich, Anna-Maria"},{"given":"Marcus A.","role":"aut","display":"Mall, Marcus A.","family":"Mall"},{"family":"Stahl","display":"Stahl, Mirjam","given":"Mirjam","role":"aut"}],"language":["eng"]} 
SRT |a STEINKEEVATRACKCFPRO2022